Metagenomi Therapeutics reported its financial results for the quarter ended June 30, 2026, along with business updates, in a press release issued on August 10, 2026. That press release is attached as Exhibit 99.1 to this 8-K. The filing is marked as "furnished" rather than "filed," meaning the information doesn't carry the usual legal liability under Section 18 of the Exchange Act. The 8-K itself just announces the results — no actual numbers are included in the excerpt, so it's not possible to say how the quarter went from this document alone.
View Full Filing (SEC EDGAR)